发明公开
- 专利标题： Novel polypeptides involved in immune response
- 专利标题（中）： 一种免疫缺陷病毒多肽
-
申请号： EP10010891.9申请日： 2000-01-27
-
公开(公告)号： EP2332976A1公开(公告)日： 2011-06-15
- 发明人: Yoshinaga, Steven Kiyoshi
- 申请人： Amgen, Inc
- 申请人地址： One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 专利权人： Amgen, Inc
- 当前专利权人： Amgen, Inc
- 当前专利权人地址： One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 代理机构： Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
- 优先权： US244448 19990203; US264527 19990308
- 主分类号： C07K14/705
- IPC分类号： C07K14/705 ; C12N15/00 ; C07K16/28
摘要：
Novel polypeptides which comprise a receptor-ligand pair involved in T-cell activation are disclosed. Nucleic acid molecules encoding said polypeptides, and vectors and host cells for expressing same are also disclosed. The polypeptides, or agonists and antagonists thereof, are used to treat T-cell mediated disorders.
公开/授权文献
- EP2332976B1 Novel polypeptides involved in immune response 公开/授权日：2014-04-02
信息查询
